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Colony-stimulating factor I (CSF-1) is a homodimeric glycoprotein growth
has been shown to regulate the survival, proliferation, and differen-
tiation of mononuclear phagocytes (reviewed in 1). Its receptor is a 165 kd ty-
rosine kinase, closely related or identical to the c-fms protooncogene product (2).
Extensive studies in vitro (1, 3), and preliminary in vivo experiments (E. R.
Stanley, and T . R. Bradley, unpublished observations) indicate that CSF-I
selectively regulates mononuclear phagocyte production. However, other possi-
ble effects of CSF-I were suggested by a study (4) in which high levels of colony-
stimulating activity were foundin pregnant uterus and fetal tissues. Furthermore,
recent observations (5) have shown the existence of the CSF- I receptor and the
cjms gene product in human choriocarcinoma. cell lines. In this paper, we find
that pregnancy induces a 1,000-fold increase in the murine uterine CSF-I
concentration, which appears to be regulated by chorionic gonaclotrophin (CG).
These observations suggest a novel role for CSF-I in pregnancy.
Materials and Methods
Endotoxin-unresponsive 8-12-wk-old C3H/HeJ mice (The Jackson Laboratory, Bar
Harbor, ME) were used exclusively. Females were mated, and day zero of pregnancy was
established when a vaginal plug was observed. Ovariectomy was performed via a dorsal
incision as described Q Purified human CG (HCG, CR123, 9,000 IU/mg proem; Dr.
Canfield, Center for Population Research, National Institute of Child Health and Human
Development, National Institutes of Health, Bethesda, MD), was administered i.p. (1,000
IU/mouse) at daily intervals. At various times after the treatments described in the text,
animals were decapitated, bled, and tissues were processed as described below.
Extraction of tissues for CSF-1 determination was carried out at VC. The
suspended in four volumes (wt/vol) of a-MEM (KC Biological, Lenexa, KS) containing 25
mM Hepes (Gibco Laboratories, Grand Island, NY), 0.2% (wt/vol) BSA (Sigma Chemical
Co., St. Louis, MO), and 0.02% NaN3, pH 7.3, and homogenized by 20 strokes of an
Eberbach (7265; Fischer Scientific Co., Pittsburgh, PA) homogenizes. The homogenate
was adjusted to 50 mg wet weight of tissue per milliliter and centrifuged at 800 g for 10
min, The supernatant fluid was heated to 56'C for 30 min, centrifuged at 800 g for 10
min, and dilutions of the supernatant were assayed in duplicate in the CSF-1 RIA (3). 1
U of CSF-I represents -0.44 fmol (7).
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TABLE I
Tissue CSF-1 Concentrations in Male, Female, and Pregnant Mice
There was no significant change in CSF-I concentration in any tissue at day 5 of
pregnancy; 10-d pregnant mice were used for these experiments. At term, whole
organ wet weights were determined. Increases were observed for liver (100%),
kidney (23%) and spleen (13%). No change was observed in ovary or lung.
* n = 3, mean ± SD.
* Significant differences, male vs. female,p < 0.05.
6 Significant difference pregnancy vs. female p < 0.05 (student t-test).
Colony formation (>40 cells/colony) by CSF-1-dependent colony-forming units (CFU-
C) in single-cell suspensions of bone marrow and spleen wascarried out in agar culture in
the presence of mouse L cell CSF-1 (300 U/ml)as described elsewhere (7).
Results
Tissue CSF-1 Concentration in Adult Male and Female Mice.
￿
CSF-1 concentra-
tions were determined by an RIA that has been shown (3) to specifically measure
biologically active CSF-1. The use of this assay obviated problems associated with
tissue-derived inhibitors of biological assays (S). Several methods of CSF-1
extraction from tissues were tested, including freeze-thawing and heating at
different temperatures. Theselected method was the most efficient for extraction
of CSF-1, and known amounts of L cell CSF-1 added to tissue extracts before
homogenization were quantitatively recovered (data not shown).
Before studies with pregnant animals, tissue CSF-1 levels in male and female
C3H/Hej mice were determined (Table I). With the exception of the submaxil-
lary salivary gland and spleen, in which higher levels were observed in males, no
sex difference was observed. The highest CSF-1 concentrations were found in
submaxillary glands, lung, spleen, and kidney, respectively.
Effect ofPregnancy on CSF-1 and CSF-1-responsive Cells.
￿
CSF-1 concentrations
in all tissues except ovary and brain increased during pregnancy (Table I) . This
increase was two- to threefold in most tissues, and less marked (1 .4-fold, see
Table I) in serum. Correlated with the increased concentration of CSF-1 in the
serum, there was a marked increase (5 .2-fold) in the concentration of circulating
monocytes, and a slight increase in the concentration of neutrophils (1 .7-fold).
The effects were selective, in that the eosinophil concentration did not change.
The increase in proportion of monocytes and neutrophils occurred primarily at
the expense of a decrease in the concentration of lymphocytes. In addition, the
hematocrit was lower in pregnant mice (Table II).
Because of a marked increase in monocyte concentration, the concentrations
of mononuclear phagocyte precursor cells (CFU-C) in the bone marrow and
Tissue
CSF-1
Male
concentration (U/mg
Female
tissue)*
Pregnant
Submaxillary gland 8.70 ± 0.13 4.80 ± 0.92= 7.60 ± 1 .816
Lung 2.40 ± 0.22 2.20 ± 0.30 4.70 ± 0.106
Spleen 2.20 ± 0.19 1 .50 t 0.09* 2.03 ± 0.201
Kidney 1 .90 ± 0.19 2.30 ± 0.21 5.80 ± 0.916
Lymph nodes 1 .43 t 0.19 1 .26 ± 0.48 2.46 ± 0.256
Brain 1 .10±0.10 0.90±0.32 0.85±0.12
Liver 0.66 ± 0.22 0.30 f 0.20 0.66 t 0.156
Testis 0.35 ± 0.20 - -
Ovary - 0.72 ± 0.09 1 .06 ± 0.20
Urine (U/,uI) 0.73 ± 0.02 0.64 t 0.10 0.86 t 0.046
Serum (U/,Ul) 1 .27 ± 0.16 0.99 f 0.11 1 .43 ± 0.05695 8
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TABLE II
Differential Peripheral Cell Count and Hematocrit During Pregnancy
Mean ± SD of triplicate counts of 3200 cells each, per animal . Figures in parentheses are percentages . No basophilic granulocytes were
observed in eitherpregnant or control animals.
* Statistically significant (p <0.05) difference between pregnant and control (student's t test) .
No statistically significant difference .
TABLE III
Bone Marrow and Splenic CFU-C During Pregnancy
CFU-C (colonies >40 cells) were calculated as the mean of individual estimates
from single animals (mean of triplicate determinations per animal) per 7.5 X 104
bone marrow and 7.5 X 10' spleen cells, and expressed as a ratio of the controls
set at 1 .0 . Numbers in parentheses indicate the number of animals (n) .
* SD (bone marrow) or range (spleen) . Average control numbers were 61 colonies
for bone marrow and 35 colonies for spleen . Cluster formation (<40 cells)
displayed the same pattern of effects as observed for colonies. The effect of
pregnancy was not significant for bone marrow CFU-C, butwas significant (p <
0.001) for spleen CFU-C.
spleen were determined . By day 5 of pregnancy, CFU-C concentrations were
elevated 2.6-fold in the spleen . This increase was sustained throughout pregnancy
(Table III) . In contrast, pregnancy had little effect on bone marrow CFU-C.
These findings, together with the differential white cell counts, indicate that
monocytopoiesis is selectively elevated at relatively early stages ofpregnancy.
Marked Elevation of Concentration of Uterine CSF-1 During Pregnancy.
￿
In con-
trast to the roughly twofold increase in CSF-1 concentration in most tissues and
serum (Table I and Fig . 1) there was a dramatic and sustained rate of increase
in the uterine CSF-1 concentration throughout pregnancy (Fig . 1) . In fact, at
term, the 1,000-fold increase in concentration, coupled with the ^'10-fold in-
crease in uterine weight resulted in a total uterine CSF-I content of ^"4 x 105
U . The elevation in uterine CSF-1 concentration was accompanied by a slight
increase in the level of fetal CSF-1, while the placental CSF-I concentration
remained constant (Fig. 1) .
In mice, the luteal phase is only begun after fertilization of the ovum, by the
production ofmurine CG (9) . To determine whetherCGwould mimic the effects
of early pregnancy on uterine CSF-1 concentration, human CG (HCG) was
administered to normal females over a 5-d period, and the uterine and serum
CSF-1 concentrations were determined . There was five- to sixfold increase in
uterine CSF-I concentration (Table IV), to concentrations that closely matched
the levels observed at day 5 of pregnancy. Because the primary site of action of
Days of pregnancy
Bone marrow
CFU-C
Spleen
Nonpregnant 1.0±0.05* 1 .0 ±0.05
5-10 1 .27 ± 0.03 (3) 2.61 ± 0.15 (2)
11-15 1 .50±0.29 (4) 2.10 ±0.42 (2)
16-20 1 .30 ± 0.25 (5) 1 .47 ± 0.18 (2)
Mice White blood
cells Lymphocytes Monocytes
cells/ml
Granulocytes
Neutrophils Eosinophils
Hematocrit
Nonpregnant 4,850 ± 570 2,764 ±222 (57.6) 161 ± 28 (3 .4) 1,600t 167 (33.3) 274± 55 (5.7) 51 .0 ± 1 .8
(n = 3)
16-20-d pregnant 5,950t 370 1,770± 173* (30.5) 826t 220* (14.3) 2,699± 487* (46.6) 501 t140; (8 .6) 41 .0 t2.9*
(n = 4)BARTOCCI ET AL.
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FIGURE 1.
￿
CSF-1 concentration in theuterus, placenta, fetus, and serum during pregnancy.
Points represent the means of triplicate determinations of individual animals for uterine (0)
and maternal serum(A) CSF-1 concentations. Placental(Q)and fetal (A) CSF-1 concentrations
arethe means of determinations on threeanimalsperformed in triplicate ±SD.
Effect ofHCG on Uterine CSF-1 Concentration
CSF-1 concentration
Animals
Normal female
Ovariectomized female
* n = 3, mean f SD.
# HCG (1,000 U/mouse) was injected i.p. at daily intervals before killing on day 5. In two
other independent experiments, the effect of this dose of HCG over the control untreated
female was 2.7-and 3.4-fold. Maximum effects of HCGwerealso observed at 1 U/mouse/d.
Theeffect of HCGwas significant p< 0.001 by student's t test.
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CG is the ovary (9), we looked at the effect of ovariectomy on these responses to
HCG. Using a comparable regime for the administration of HCG, ovariectomy
completely inhibited the elevation of uterine CSF-I concentrations (Table IV).
These data suggest that the early changes in CSF-I concentrations in pregancy
are regulated by CG via its influence on ovarian function .
Discussion
The method developed for the measurement of tissue CSF-I provided a
reliable means of measuring biologically active CSF-I. The relative distribution
of CSF-I in the tissues of normal male and female mice paralleled to a large
degree the previously reported (8) distribution of colony-stimulating activity.
However, colony-stimulating activity determined by in vitro bioassay could have
resulted from the activities of several distinct CSFs, including GM-CSF (granu-
Treatment Serum
(U/dal)
Uterus
(U/mg)
Uterine
weight (mg)
Saline 1 .4 t 0.2* 2.5 ±0.5 54.2 t 11 .1
HCGf 1 .9 ± 0.2 13.8 ±0.9 68.9 t 1.9
Saline 1.6 ± 0.2 2.0 t0.3 33.3 ± 3.2
HCG 1 .7 ± 0.2 2.2 ±0.4 29.3 t 1.15960
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locyte/macrophage CSF), G-CSF (granulocyte CSF), and IL-3 (reviewed in 10)
that are not detected by the CSF-1 RIA (3).
The concentrations of nonuterine tissue and serum CSF-1 were significantly
elevated between days 5 and 10 of pregnancy. During this period, there was an
increase in the concentration of splenic CFU-C. This effect was correlated with
monocytosis and granulocytosis, although the kinetics of these increases were
not determined in the present study. These results are consistent with an in vivo
role of CSF-1 in the regulation of mononuclear phagocyte production. Similar
changes in the differential white cell count and hematocrit have been reported
for studies of pregnancy in humans (11, 12).
In contrast to the other tissues examined, the kinetics ofthe increase in uterine
CSF-1 concentration was more rapid and far greater in extent. A5-fold increase
in the CSF-1 concentration was already apparent at day 5, reaching 1,000-fold
by term. In fact, by term, the total CSF-1 content of the uterus (^-5 X 105 U) far
exceeded the total CSF-1 content ofthe other tissues. At present, it is not clear
whetherthe increase in uterine CSF-1 contributesto, orresults from, the increase
in serum CSF-1, or is, alternatively, a local phenomenon. The data indicate that
increases in uterine CSF-1 are under the control ofCG, mediated by the ovary.
Ovarian involvement could be due either to the production of progestins and
estrogens, known to be regulated by CG, or to as yet uncharacterized ovarian
factors.
In view of the presence of cfms mRNA in human placenta (13), and its
occurrence, together with CSF-1 receptor, in choriocarcinoma cell lines with
trophoblastic morphology (5), it has been suggested that CSF-1 may play a role
in placental development. Our data are consistent with this possibility. The
placenta is composed ofboth fetally-derived trophoblasts and maternally-derived
decidual cells. Interestingly, it has been shown (14, 15) that at least some of the
decidual cells arise from bone marrow precursors. Uterine CSF-1 may also cause
local proliferation and differentiation of cells of the mononuclear phagocytic
lineage, giving rise to mature macrophages. Macrophages have been identified
on the maternal side of the fetal-maternal border of the placenta (16), where
they may contribute to the immunosuppression ofthe maternal response to the
allogeneic fetus (17). These questions may be approached by identification of
CSF-1-producing and -responding cells in situ.
Summary
Pregnancy results in an elevation in serum and tissue concentrations of the
mononuclear phagocytic growth factor, CSF-1 (colony-stimulating factor 1).
These increases are associated with an increase in the number of monocytes in
the circulation, and with increases in the number of splenic macrophage precur-
sors. In contrast to the ^-2-fold elevation of the CSF-1 concentrations in serum
and most tissues, pregnancy results in a 1,000-fold increase in the concentration
of uterine CSF-1 . The roughly fivefold elevation in uterine CSF-I concentration
observed at day 5 ofpregnancy could be mimicked by administration ofchorionic
gonadotrophin in intact but not ovariectomized mice . These dramatic changes
in uterine CSF-1 concentrations may indicate a role for CSF-1 in the regulation
of nonmononuclear phagocytic cell types.BARTOCCI ET AL.
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